Kingdomway: Subsidiary obtains invention patent for "Preparation of 6-Chloro-6-Oxocaproic Acid Ethyl Ester"Zhitong·Nov 3, 2025 at 01:45 AM002626+0.57%
Kingdomway released its performance for the first three quarters, with a net profit attributable to the parent company of 361 million yuan, a year-on-year increase of 63.47%Zhitong·Oct 24, 2025 at 10:08 AM002626+0.57%
Kingdomway's subsidiary has obtained the approval number for veterinary drug productsZhitong·Sep 10, 2025 at 04:10 AM002626+0.57%
Kingdomway released its performance for the first half of the year, with a net profit attributable to the parent company of 247 million yuan, a year-on-year increase of 90.12%Zhitong·Aug 27, 2025 at 08:04 AM002626+0.57%
Kingdomway: The company's convertible bonds will be available for subscription starting August 20Zhitong·Aug 17, 2025 at 04:28 AM002626+0.57%
Kingdomway's subsidiary and Aibede jointly established a joint venture to promote the application of nanocrystal production technologyZhitong·Aug 4, 2025 at 03:31 AM002626+0.57%
Kingdomway issued a profit forecast, expecting a net profit attributable to the parent company of 221 million to 260 million yuan in the first half of the year, a year-on-year increase of 70%–100%Zhitong·Jul 14, 2025 at 06:21 AM002626+0.57%
Kingdomway: Ergothioneine products are sold domestically through cross-border e-commerce platformsZhitong·May 21, 2025 at 03:56 AM002626+0.57%
Kingdomway: The company is currently not involved in the production of ergotamine raw materialsZhitong·May 19, 2025 at 10:47 PM002626+0.57%
The concept of large consumption continues to rise, with multiple stocks including Hyea Aromas hitting the daily limitZhitong·May 15, 2025 at 12:45 AM002626+0.57%300886+1.90%
Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit a 20% limit upZhitong·May 14, 2025 at 08:55 PM301301+0.81%002626+0.57%
Kingdomway released its first-quarter performance, with a net profit attributable to the parent company of 122 million yuan, a year-on-year increase of 71.97%Zhitong·Apr 28, 2025 at 03:55 AM002626+0.57%
Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoonZhitong·Apr 10, 2025 at 01:27 AM603079+0.46%301206+0.82%
